hrp0086p1-p814 | Syndromes: Mechanisms and Management P1 | ESPE2016
Musthaffa Yassmin
, Scheermeyer Elly
, Hughes Ian
, Harris Mark
, Crock Patricia
, Leong Gary
Background: Normal TF is necessary for optimal growth. Changes in the hypothalamic-pituitary-thyroid (HPT) axis following GH therapy are reported. GH therapy has been suggested to centrally inhibit TSH production as well as peripherally increasing T4 to T3 conversion which increases negative feedback on TSH production. Hypothalamic dysfunction is a feature of PWS, therefore these patients may be at risk of developing central hypothyroidism associated with GH therapy.<p cla...